Thomas Steyer’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,278,900
| Closed | -$277M | – | 390 |
|
|
2021
Q1 | $277M | Buy |
+1,278,900
| New | +$240M | 1.38% | 29 |
|
|
2017
Q2 | – | Sell |
-250,000
| Closed | -$30.2M | – | 89 |
|
|
2017
Q1 | $30.2M | Buy |
250,000
+102,072
| +69% | +$12.5M | 0.33% | 50 |
|
|
2016
Q4 | $16.5M | Buy |
147,928
+116,928
| +377% | +$14.1M | 0.19% | 49 |
|
|
2016
Q3 | $4.12M | Sell |
31,000
-9,000
| -23% | -$860K | 0.06% | 59 |
|
|
2016
Q2 | $3.66M | Sell |
40,000
-20,000
| -33% | -$1.68M | 0.05% | 60 |
|
|
2016
Q1 | $4.33M | Buy |
+60,000
| New | +$3.29M | 0.04% | 69 |
|
|
2015
Q3 | – | Sell |
-60,000
| Closed | -$7.37M | – | 102 |
|
|
2015
Q2 | $7.37M | Buy |
+60,000
| New | +$6.81M | 0.1% | 74 |
|
|
2014
Q4 | – | Sell |
-244,000
| Closed | -$19.7M | – | 102 |
|
|
2014
Q3 | $19.7M | Sell |
244,000
-108,500
| -31% | -$9.6M | 0.32% | 59 |
|
|
2014
Q2 | $37.8M | Sell |
352,500
-311,500
| -47% | -$21.7M | 0.55% | 46 |
|
|
2014
Q1 | $39.4M | Buy |
664,000
+80,000
| +14% | +$4.76M | 0.77% | 35 |
|
|
2013
Q4 | $24.3M | Hold |
584,000
| – | – | 0.5% | 48 |
|
|
2013
Q3 | $10.1M | Buy |
584,000
+24,000
| +4% | +$276K | 0.21% | 54 |
|
|
2013
Q2 | $4.93M | Buy |
+560,000
| New | +$4.96M | 0.09% | 67 |
|
Other funds holding GWPH
Thomas Steyer's GWPH Position: Q2 2021 in Review
Thomas Steyer sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1,278,900 shares — an estimated $277M sold.
Thomas Steyer first reported a position in GWPH in Q2 2013 and held it in 13 quarters. The position peaked at $277M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Thomas Steyer reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Thomas Steyer sold 1,278,900 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $277M.
- Thomas Steyer first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2013 and held it in 13 quarters.
- Thomas Steyer's GW Pharmaceuticals Plc American Depositary Shares position peaked at $277M in Q1 2021.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Farallon Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.